Sun Pharma Advanced Research Company informs about press release

10 Apr 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company that it enclosed the Press Release titled ‘SPARC Announces Results from the Planned Interim Analysis of the PROSEEK Study of Vodobatinib in Patients with Early Parkinson’s Disease’, which the company will be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

127.65 -2.80 (-2.15%)
20-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Syngene Internation. 622.55
Indegene 478.30
CMS Info Systems 325.30
Sagility 53.29
Smartworks Coworking 443.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×